| Dr Michael John Gorz, OD | |
|
1021 Jefferson St, Algoma, WI 54201-1737 | |
| (920) 487-2020 | |
| Not Available |
| Full Name | Dr Michael John Gorz |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 1021 Jefferson St, Algoma, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750867149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3514-35 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeshore Vision Centers, Ltd | 9133200900 | 3 |
News Archive
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Medical "report cards" intended to improve the quality of health care may sometimes reduce it for racial and ethnic minorities, according to a report in a special disparities themed issue of Circulation: Journal of the American Heart Association.
Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.
Rutgers researchers have found a way to reduce bleeding in patients following bariatric surgery.
› Verified 2 days ago
| Provider Name | Lakeshore Vision Centers, Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780734418 PECOS PAC ID: 9133200900 Enrollment ID: O20080117000651 |
News Archive
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Medical "report cards" intended to improve the quality of health care may sometimes reduce it for racial and ethnic minorities, according to a report in a special disparities themed issue of Circulation: Journal of the American Heart Association.
Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.
Rutgers researchers have found a way to reduce bleeding in patients following bariatric surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael John Gorz, OD 1021 Jefferson St, Algoma, WI 54201-1737 Ph: (920) 487-2020 | Dr Michael John Gorz, OD 1021 Jefferson St, Algoma, WI 54201-1737 Ph: (920) 487-2020 |
News Archive
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Medical "report cards" intended to improve the quality of health care may sometimes reduce it for racial and ethnic minorities, according to a report in a special disparities themed issue of Circulation: Journal of the American Heart Association.
Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.
Rutgers researchers have found a way to reduce bleeding in patients following bariatric surgery.
› Verified 2 days ago
Dr. John Edward Gorz, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1021 Jefferson St, Algoma, WI 54201 Phone: 920-487-2020 Fax: 920-487-5022 |